3:30pm-5:00pm on Thursday 28 March
Times shown are in GMT (UTC +0) up to the 26th March. For events on or after 27th March times are in BST (UTC +1).
MRC Cognition and Brain Sciences Unit, 15 Chaucer Road, CB2 7EF
Dementia currently affects 55 million people across the world. One in three of us is on course to develop dementia, with huge personal, health and economic impact. Better prevention, earlier diagnosis and effective treatments are urgently needed.
In 2023, our team discussed the causes of dementia and how we can reduce the risks. This year, we will discuss the development of new treatments to slow or halt the illness. We will also discuss the difference between normal ageing and dementia. And the role of genes.
The headlines in 2022 and 2023 raised hopes of a major breakthrough in dementia treatment and, at time of writing, two new designer antibody-type ‘drugs’ are under review for use in the UK. Regardless of whether they are granted approval here in the UK, it is clear that we are at a tipping point for dementia, which heralds a major change in expectations for diagnosis, care and even a cure.
Dementia researchers and doctors from the University of Cambridge will discuss this fast-moving area and emerging treatments for dementia.
Our in-person presentations will be followed by a Q&A session on:
• Nature versus nurture: what is the role of genes in dementia?
• What have we learned from healthy ageing, and how it differs from dementia?
• Emerging dementia treatments: hype or reality?
